{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:41:02Z","timestamp":1791484862181,"version":"4.3.4"},"reference-count":29,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T00:00:00Z","timestamp":1561852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>Opioid misuse, abuse, and diversion continues to be a public health issue. Pharmacists (particularly those who work in the community setting) form the vanguard of health-care providers facing the opioid crisis because they have the opportunity to interact with patients more frequently than primary care or specialty medical providers. These frequent interactions give pharmacists more opportunities to properly counsel patients on prevention and to reinforce appropriate use of opioid medications. Pharmacists should be aware of the strategies for reducing opioid misuse, abuse, and diversion, including understanding mandates on prescription limitations; knowing how to use prescription drug monitoring programs; knowing when drug take-back programs are occurring; educating patients on the risks of opioid abuse, safe storage, and proper disposal of unused medications; identifying \u201cred flag\u201d behavior that may indicate opioid misuse; using assessments that help identify a patient\u2019s risk for opioid abuse; interacting with other health-care professionals to discuss a patient\u2019s care; understanding how abuse-deterrent opioids work and their limitations; preparing for opioid overdose management and understanding the local regulations on naloxone availability; and knowing when to refer patients to addiction services. Using these strategies, pharmacists have an opportunity to potentially reduce opioid abuse and improve patient outcomes.<\/jats:p>","DOI":"10.1177\/0897190019852803","type":"journal-article","created":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T23:59:35Z","timestamp":1561939175000},"page":"856-862","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":13,"title":["The Role of Pharmacists in Safe Opioid Dispensing"],"prefix":"10.1177","volume":"33","author":[{"given":"Thomas","family":"Gregory","sequence":"first","affiliation":[{"name":"Department of Pharmacy, CoxHealth, Springfield, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Gregory","sequence":"additional","affiliation":[{"name":"Alps Pharmacy, Springfield, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,6,30]]},"reference":[{"key":"bibr1-0897190019852803","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality."},{"key":"bibr2-0897190019852803","unstructured":"National Institute on Drug Abuse. Overdose death rates. https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates. Accessed October 4, 2018."},{"key":"bibr3-0897190019852803","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.2543"},{"key":"bibr4-0897190019852803","author":"Moose J","year":"2014","journal-title":"Pharmacy Times"},{"key":"bibr5-0897190019852803","doi-asserted-by":"publisher","DOI":"10.1177\/1715163517745517"},{"key":"bibr6-0897190019852803","unstructured":"National Conference of State Legislatures. Prescribing policies: states confront opioid overdose epidemic. Accessed June 4, 2018. http:\/\/www.ncsl.org\/Portals\/1\/Documents\/Health\/prescribingOpioids_final01-web.pdf"},{"key":"bibr7-0897190019852803","unstructured":"Serafini M. The physicians\u2019 quandary with opioids: pain versus addiction. Accessed June 29, 2018. https:\/\/catalyst.nejm.org\/quandary-opioids-chronic-pain-addiction\/"},{"key":"bibr8-0897190019852803","unstructured":"Centers for Disease Control and Prevention. Prescription drug monitoring programs (PDMPs). Accessed June 4, 2018. https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pdmp_factsheet-a.pdf"},{"key":"bibr9-0897190019852803","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2017.1321"},{"key":"bibr10-0897190019852803","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.12.002"},{"key":"bibr11-0897190019852803","unstructured":"National Association of Boards of Pharmacy. PMP InterConnect. Accessed June 4, 2018. https:\/\/nabp.pharmacy\/initiatives\/pmp-interconnect\/"},{"key":"bibr12-0897190019852803","unstructured":"Drug Enforcement Administration. 15th National Take Back Day. Accessed June 4, 2018. https:\/\/takebackday.dea.gov\/sites\/default\/files\/NTBI%20XV%20Totals.pdf"},{"key":"bibr13-0897190019852803","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2016.1240801"},{"key":"bibr14-0897190019852803","unstructured":"Food and Drug Administration. Disposal of unused medicines: what you should know. Accessed June 4, 2018. https:\/\/www.fda.gov\/Drugs\/ResourcesForYou\/Consumers\/BuyingUsingMedicineSafely\/EnsuringSafeUseofMedicine\/SafeDisposalofMedicines\/ucm186187.htm"},{"key":"bibr15-0897190019852803","unstructured":"Food and Drug Administration. Where and how to dispose of unused medicines. Accessed June 19, 2018. https:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm101653.htm"},{"key":"bibr16-0897190019852803","unstructured":"National Association of Boards of Pharmacy. Stakeholders\u2019 challenges and red flag warning signs related to prescribing and dispensing controlled substances. Accessed July 2, 2018. https:\/\/nabp.pharmacy\/wp-content\/uploads\/2016\/07\/Red-Flags-Controlled-Substances-03-2015.pdf"},{"key":"bibr17-0897190019852803","unstructured":"Centers for Disease Control and Prevention. Pharmacists: on the front lines. Accessed June 5, 2018. https:\/\/www.cdc.gov\/drugoverdose\/pdf\/Pharmacists_Brochure-a.pdf"},{"key":"bibr18-0897190019852803","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2015.01.475"},{"key":"bibr19-0897190019852803","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2013.04.014"},{"key":"bibr20-0897190019852803","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ptdy.2018.10.031","volume":"24","author":"D\u2019Arrigo T","year":"2018","journal-title":"Pharmacy Today"},{"key":"bibr21-0897190019852803","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1419171"},{"key":"bibr22-0897190019852803","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000034"},{"key":"bibr23-0897190019852803","unstructured":"Substance Abuse and Mental Health Services Administration Center for the Application of Prevention Technologies. Preventing the consequences of opioid overdose: understanding naloxone access laws. Accessed June 7, 2018. https:\/\/www.samhsa.gov\/capt\/sites\/default\/files\/resources\/naloxone-access-laws-tool.pdf"},{"key":"bibr24-0897190019852803","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-015-0058-x"},{"key":"bibr25-0897190019852803","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014523730"},{"key":"bibr26-0897190019852803","unstructured":"National Alliance of State Pharmacy Associations. Naloxone access in community pharmacies. Accessed June 6, 2018. https:\/\/naspa.us\/resource\/naloxone-access-community-pharmacies\/"},{"key":"bibr27-0897190019852803","unstructured":"Surgeon General. Surgeon general\u2019s advisory on naloxone and opioid overdose. Accessed June 6, 2018. https:\/\/www.surgeongeneral.gov\/priorities\/opioid-overdose-prevention\/naloxone-advisory.html"},{"key":"bibr28-0897190019852803","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-1-3"},{"key":"bibr29-0897190019852803","unstructured":"Drug Enforcement Administration. Title 21 Code of Federal Regulations, Part 1306\u2014Prescriptions. Accessed June 7, 2018. https:\/\/www.deadiversion.usdoj.gov\/21cfr\/cfr\/1306\/1306_04.htm"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190019852803","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0897190019852803","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190019852803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:35:32Z","timestamp":1777509332000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0897190019852803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,30]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1177\/0897190019852803"],"URL":"https:\/\/doi.org\/10.1177\/0897190019852803","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,30]]}}}